Eric Senn
Family Medicine · Myrtle Beach, SCNPI 1295733012
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $949 and has fallen 55.0% since, to $427 in 2023.
Across 164 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$558
- AstraZeneca$545
- AbbVie$482
- Amgen$200
- Novo Nordisk$172
- Abbott$162
- plus $803 from 19 others
What the payments were for
- Food & beverage$2,907100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 33 | $558 |
| AstraZeneca | 17 | $545 |
| AbbVie(2 entities) | 40 | $482 |
| Amgen | 14 | $200 |
| Novo Nordisk | 11 | $172 |
| Abbott | 3 | $162 |
| Pfizer | 11 | $155 |
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| Amarin Pharma, Inc. | 5 | $84 |
| Boehringer Ingelheim | 4 | $74 |
| Sanofi-aventis U.S. LLC | 4 | $67 |
| Merck | 4 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Exact Sciences | 2 | $28 |
| Lilly USA, LLC | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $18 |
| Novartis | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,921 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 18 | $277 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Myrtle Beach
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.